Evidence map›Paper›PMID 40374854›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.

Chitra Vinnakota, Matthew R Hudson, Kazutaka Ikeda, Soichiro Ide, Masayoshi Mishina, Suresh Sundram, Nigel C Jones, Rachel Anne Hill

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Synaptic dysfunction and adaptation after NMDA receptor ablation in the mouse medial prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chitra Vinnakota *Department of Psychiatry, Monash University, Clayton, VIC, 3168, Australia.
Matthew R Hudson *Department of Neuroscience, Monash University, Melbourne, VIC, Australia.
Kazutaka IkedaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.ORCID http://orcid.org/0000-0001-8342-0278
Soichiro IdeAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.
Masayoshi MishinaBrain Science Laboratory, The Research Organization of Science and Technology, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, Japan.
Suresh SundramDepartment of Psychiatry, Monash University, Clayton, VIC, 3168, Australia.ORCID http://orcid.org/0000-0002-9674-0227
Nigel C JonesDepartment of Neuroscience, Monash University, Melbourne, VIC, Australia. nigel.jones@monash.edu.ORCID http://orcid.org/0000-0002-1080-8439
Rachel Anne HillDepartment of Psychiatry, Monash University, Clayton, VIC, 3168, Australia. Rachel.hill@monash.edu.ORCID http://orcid.org/0000-0001-6111-355X

Funding

Department of Health | National Health and Medical Research Council (NHMRC) GNT2000893
6 · The paper itself

Abstract

Working memory relies on synchronised network oscillations involving complex interplay between pyramidal cells and GABAergic interneurons. NMDA receptor (NMDAR) antagonists influence both network oscillations and working memory, but the relationship between these two consequences has not been elucidated. This study aimed to determine the effect of NMDAR antagonists on network oscillations during a working memory task in mice, and the contribution of the GluN2D receptor subunit. After training wildtype (WT) and GluN2D-knockout (KO) mice on the Trial-Unique-Non-match to Location (TUNL) touchscreen task of working memory, recording electrodes were implanted into the prefrontal cortex (PFC) and hippocampus. Mice were challenged with either (S)-ketamine (30 mg/kg), (R)-ketamine (30 mg/kg), phencyclidine (PCP, 1 mg/kg), MK-801 (0.3 mg/kg) or saline prior to TUNL testing while simultaneous local field potential recordings were acquired. PCP disrupted working memory accuracy in WT (p = 0.001) but not GluN2D-KO mice (p = 0.79). MK-801 (p < 0.0001), (S)-ketamine (p < 0.0001) and (R)-ketamine (p = 0.007) disrupted working memory accuracy in both genotypes. PCP increased baseline hippocampal gamma (30-80 Hz) power in WT (p = 0.0015) but not GluN2D-KO mice (p = 0.92). All drugs increased baseline gamma power in the PFC in both genotypes (p < 0.05). Low gamma was induced during the maintenance phase of the TUNL task and increased when mice correctly completed the task (p = 0.024). This response-dependent increase in low gamma was disrupted by all drugs. In summary, PCP action involves the GluN2D subunit of the NMDA receptor in the hippocampus to alter baseline gamma power and working memory. Task-induced low gamma activity during maintenance aligns with task performance, and is disrupted by all NMDAR antagonists.

Indexed as

Excitatory Amino Acid AntagonistsGamma RhythmMemory, Short-TermReceptors, N-Methyl-D-AspartateAnimalsDizocilpine MaleateHippocampusKetamineMaleMiceMice, Inbred C57BLMice, KnockoutPhencyclidinePrefrontal CortexDizocilpine MaleateExcitatory Amino Acid AntagonistsKetamineNR2D NMDA receptorPhencyclidineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID40374854
PMCPMC12603283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.